You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation
|
|---|---|
| Published in |
European Journal of Cancer (1965), May 2019
|
| DOI | 10.1016/j.ejca.2019.04.006 |
| Pubmed ID | |
| Authors |
Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, Jean-Marc Schiano, Olivier Casasnovas, Aspasia Stamatoullas, Bénédicte Deau, Anna Schmitt, Georges Garnier, Caroline Regny, Krimo Bouabdallah, Marie-Pierre Moles-Moreau, Hervé Ghesquieres, Adrian Tempescul, Remy Dulery, Emmanuelle Nicolas-Virelizier, Alain Delmer, Cecile Borel, Adrien Chauchet, Diane Damotte, Laurent Dercle, Pauline Brice, Roch Houot, LYSA |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 9 | 21% |
| Spain | 6 | 14% |
| United States | 2 | 5% |
| Brazil | 2 | 5% |
| Mexico | 2 | 5% |
| United Kingdom | 1 | 2% |
| Portugal | 1 | 2% |
| Peru | 1 | 2% |
| India | 1 | 2% |
| Other | 2 | 5% |
| Unknown | 15 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 71% |
| Scientists | 6 | 14% |
| Practitioners (doctors, other healthcare professionals) | 5 | 12% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 36 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 5 | 14% |
| Researcher | 4 | 11% |
| Student > Ph. D. Student | 3 | 8% |
| Student > Postgraduate | 3 | 8% |
| Professor > Associate Professor | 2 | 6% |
| Other | 3 | 8% |
| Unknown | 16 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 36% |
| Biochemistry, Genetics and Molecular Biology | 2 | 6% |
| Nursing and Health Professions | 2 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Immunology and Microbiology | 1 | 3% |
| Other | 3 | 8% |
| Unknown | 14 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2019.
All research outputs
#1,396,158
of 25,462,162 outputs
Outputs from European Journal of Cancer (1965)
#259
of 6,879 outputs
Outputs of similar age
#30,965
of 364,616 outputs
Outputs of similar age from European Journal of Cancer (1965)
#9
of 71 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,879 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,616 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.